Peer-reviewed veterinary case report
iCatCare 2025 consensus guidelines on the diagnosis and management of diabetes mellitus in cats.
- Journal:
- Journal of feline medicine and surgery
- Year:
- 2025
- Authors:
- Taylor, Samantha et al.
- Affiliation:
- International Cat Care · United Kingdom
- Species:
- cat
Plain-English summary
Diabetes mellitus (DM) is a common hormonal disease in cats, and recent advancements have led to more treatment options, including different types of insulin and new oral medications. Continuous glucose monitoring (CGM) devices are now being used more frequently, giving veterinarians better insights into how affected cats are doing. Managing diabetes in cats can be tricky, especially since some may have other health issues that complicate treatment. It's important for pet owners to work closely with their veterinarian to choose the best treatment plan, which may involve insulin or other medications, along with a suitable diet and regular monitoring. The guidelines emphasize that with the right approach, managing diabetes in cats can be very rewarding.
Abstract
PRACTICAL RELEVANCE: Diabetes mellitus (DM) is a common feline endocrine disease. Developments in therapy mean there are now more options for treatment, including various types of insulin and novel oral medications. Use of continuous glucose monitoring (CGM) devices has increased, providing more detailed information on affected cats. Selecting the appropriate treatment for DM, monitoring the cat's response and treating complications can present challenges, but these patients are nonetheless rewarding cases to manage for clinicians. AIM: The '2025 iCatCare consensus guidelines on the diagnosis and management of diabetes mellitus in cats' provide practical information on the management of complex as well as more routine cases. The importance of a team approach, involving veterinary professionals and the caregiver, is emphasised as this is likely to optimise patient outcomesClinical challenges:The pathogenesis of DM in cats, including absolute or relative insulin deficiency, can complicate management. Moreover, conditions such as hypersomatotropism, which is a prevalent underlying cause, as well as comorbidities that are common in affected populations of cats, warrant special consideration. Selecting the most appropriate therapy for the individual cat with DM relies on a thorough assessment of the case, including testing for comorbidities, if indicated, and excellent communication with caregivers. Treatment with either insulin or sodium-glucose cotransporter-2 inhibitors may be appropriate and should be combined with a diet and a monitoring regimen that are suitable and manageable for both cat and caregiver. Monitoring, to determine the response to treatment and to detect complications such as diabetic ketoacidosis or hypoglycaemia, may include placement of a CGM device. EVIDENCE BASE: These Guidelines have been created by a panel of experts brought together by the International Cat Care (iCatCare) Veterinary Society. Information is based on the available literature, expert opinion and the panel members' experience.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/41224734/